Below is a sample of existing clinical evidence:
“hMSC (human Mesenchymal Stem Cell) infusions decreased ECM (Extracellular Matrix) deposition as evidenced by decreases in soluble and insoluble collagen production… hMSCs participate in improved outcomes of remodeling by reversing excess collagen deposition and changing hyaluronan levels.”
– “Chronic asthma and Mesenchymal stem cells: Hyaluronan and airway remodeling,” Goldstein et al, Journal of Inflammation, 2017
